Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term <scp>HeartMate</scp> 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists
In long-term, stable HM3 recipients on VKA therapy, aspirin discontinuation did not increase HRAEs. Laboratory markers of hemolysis remained stable aside from a modest, clinically insignificant rise in HI. These findings extend randomized evidence supporting aspirin avoidance at implantation to patients with long-term HM3 support and suggest simplified antithrombotic regimens may be safe in selected HM3 patients. Larger multicenter studies with longer follow-up are warranted.
Authors
- Christiane Marko
- R. Moayedifar (ORCID: https://orcid.org/0009-0001-3400-3248)
- Daniel Zimpfer (ORCID: https://orcid.org/0000-0002-2185-4895)
- Julia Riebandt (ORCID: https://orcid.org/0000-0002-8601-9989)
- Thomas Schlöglhofer (ORCID: https://orcid.org/0000-0003-4354-4860)
- Barbara Karner (ORCID: https://orcid.org/0000-0001-6277-7702)
- Melanie Arnreiter (ORCID: https://orcid.org/0009-0002-5869-1732)
- Hebe Al Asadi
- Christina Abd El‐Malak
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- Artificial Organs
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1111/aor.70059
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00